Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Am. J. Ophthalmol., Jan;145(1):12-22 (2008)
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Ophthalmology., Apr;113(4):683.e1-8 (2006)
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
Invest. Ophthalmol. Vis. Sci., Jun;52(7):4605-9 (2011)
The effects of commercially available preservative-free FDA-approved triamcinolone (TriesenceÂ®) on retinal cells in culture.
J Ocul Pharmacol Ther., Apr;27(2):143-50 (2011)
Evaluation of the toxicity of triamcinolone acetonide and dexamethasone sodium phosphate on human lens epithelial cells (HLE B-3).
J Ocul Pharmacol Ther., Jun;27(3):265-71 (2011)
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Ophthalmology., Jun;119(6):1190-8 (2012)
Drug delivery strategies for combination ophthalmic treatments.
Retina (Philadelphia, Pa.)., Jun;29(6 Suppl):S24-6 (2009)
Wet age-related macular degeneration.
Adv. Drug Deliv. Rev., Dec;57(14):1994-2009 (2005)
Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells.
Curr. Eye Res., Jun;30(6):471-8 (2005)
Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
Am. J. Ophthalmol., Oct;140(4):573-84 (2005)
Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
Am. J. Ophthalmol., Oct;140(4):585-97 (2005)
Ocular changes after photodynamic therapy.
Invest. Ophthalmol. Vis. Sci., Jan;47(1):377-85 (2006)
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.
Invest. Ophthalmol. Vis. Sci., Feb;47(2):722-8 (2006)
Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells.
Retina (Philadelphia, Pa.)., 26(5):512-8 (2006)
Uncertain compassion in using a drug before the risks and benefits are known.
Arch. Ophthalmol., Jul;124(7):1032-4 (2006)
Optical coherence tomography in progressive outer retinal necrosis.
Ophthalmic Surg Lasers Imaging., 37(6):506-7 (2006)
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.
Arch. Ophthalmol., Mar;125(3):309-17 (2007)
Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds.
Curr. Eye Res., Apr;24(4):245-52 (2002)
Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells.
Invest. Ophthalmol. Vis. Sci., Jan;46(1):304-9 (2005)
Therapeutic options for resistant cytomegalovirus retinitis.
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 14 Suppl 1:S13-21 (1997)